- Home
- FCT vs SLP Comparison
FCT vs SLP Comparison
Compare FCT & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCT | SLP |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | US |
| Employees | N/A | N/A |
| Industry | Finance Companies | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.2M | 293.5M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | FCT | SLP |
|---|---|---|
| Price | $9.99 | $12.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 91.5K | ★ 386.9K |
| Earning Date | 01-01-0001 | 04-07-2026 |
| Dividend Yield | ★ 11.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | N/A | $2.64 |
| Revenue Next Year | N/A | $6.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $8.61 | $11.76 |
| 52 Week High | $10.43 | $36.43 |
Technical Indicators
Market Signals| Indicator | FCT | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 21.52 |
| Support Level | $9.86 | $11.76 |
| Resistance Level | $9.95 | $14.78 |
| Average True Range (ATR) | 0.06 | 0.96 |
| MACD | -0.01 | -0.41 |
| Stochastic Oscillator | 53.92 | 6.26 |
Price Performance
Historical ComparisonAbout FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.